MAPT and Alzheimer disease: The analysis of likelihood ratios showed that, in both situations, a CSF test result indicating pathological values of Aβ42/p-tau or p-tau significantly increase the probability that the disease is present [in this context progression from MCI to AD or, in other words, MCI due to AD (Albert et al., 2011)].